Literature DB >> 2305838

Patterns of MHC antigenic modulation in cyclosporine-induced autoimmunity. Implications for pathogenesis.

N A Parfrey1, G J Prud'homme.   

Abstract

To explore the role of aberrant MHC expression in the pathogenesis of cyclosporine-induced autoimmunity (CSIA), we examined the patterns of major histocompatibility complex (MHC) class I and II antigenic modulation during disease induction and the relationship between MHC modulation and tissue injury. Disease was induced consistently in rats but never in mice. Unlike rats, mice were resistant to downmodulation by cyclosporine of class II antigen expression in the thymic medulla. In rats with CSIA, MHC class I and II antigen expression was induced on all target epithelia, frequently before mononuclear infiltration or tissue injury, consistent with a role for MHC antigens in selecting cells for injury. Much increased numbers of strongly class II-positive interstitial dendritic cells were present throughout the body, even in tissues not involved by CSIA. Thus, class II expression alone is insufficient to lead to cell injury in CSIA.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2305838      PMCID: PMC1877392     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  20 in total

1.  Organ-specific autoimmune disease induced in mice by elimination of T cell subsets. V. Neonatal administration of cyclosporin A causes autoimmune disease.

Authors:  S Sakaguchi; N Sakaguchi
Journal:  J Immunol       Date:  1989-01-15       Impact factor: 5.422

2.  T cells can distinguish between allogeneic major histocompatibility complex products on different cell types.

Authors:  P Marrack; J Kappler
Journal:  Nature       Date:  1988-04-28       Impact factor: 49.962

3.  Acute graft-versus-host disease in recipients of bone-marrow transplants from identical twin donors.

Authors:  J Rappeport; M Mihm; E Reinherz; S Lopansri; R Parkman
Journal:  Lancet       Date:  1979-10-06       Impact factor: 79.321

4.  Syngeneic graft-versus-host disease induced by cyclosporine--a reappraisal.

Authors:  L H Chow; L Mosbach-Ozmen; B Ryffel; J F Borel
Journal:  Transplantation       Date:  1988-08       Impact factor: 4.939

5.  Pseudo-graft-versus-host disease in heart and heart-lung recipients.

Authors:  J G Herman; W E Beschorner; K L Baughman; J K Boitnott; G B Vogelsang; W A Baumgartner
Journal:  Transplantation       Date:  1988-07       Impact factor: 4.939

6.  Leukocyte subsets in first-set rat cardiac allograft rejection. A serial immunohistologic study using monoclonal antibodies.

Authors:  R D Forbes; R D Guttmann; M Gomersall; J Hibberd
Journal:  Transplantation       Date:  1983-12       Impact factor: 4.939

7.  In vivo and in vitro production of IFN-beta and IFN-gamma during graft vs host disease.

Authors:  M G Cleveland; C R Annable; G R Klimpel
Journal:  J Immunol       Date:  1988-11-15       Impact factor: 5.422

8.  Evidence that nonlymphoid tissue injury in acute graft-versus-host disease is limited to epithelial cells aberrantly expressing MHC antigens.

Authors:  N A Parfrey; H Ste-Croix; G J Prud'Homme
Journal:  Transplantation       Date:  1989-10       Impact factor: 4.939

9.  Development of graft-vs.-host disease-like syndrome in cyclosporine-treated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal anti-Ia specificity, including autoreactivity.

Authors:  A D Hess; L Horwitz; W E Beschorner; G W Santos
Journal:  J Exp Med       Date:  1985-04-01       Impact factor: 14.307

10.  Sequential morphology of graft-versus-host disease in the rat radiation chimera.

Authors:  W E Beschorner; P J Tutschka; G W Santos
Journal:  Clin Immunol Immunopathol       Date:  1982-02
View more
  2 in total

1.  Cyclosporin A in a pregnant patient affected with systemic lupus erythematosus.

Authors:  A Doria; L Di Lenardo; S Vario; A Calligaro; E Vaccaro; P F Gambari
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

2.  Cyclosporin A markedly enhances superantigen-induced peripheral T cell deletion and inhibits anergy induction.

Authors:  L E Vanier; G J Prud'homme
Journal:  J Exp Med       Date:  1992-07-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.